# World Trade Center (WTC) RENAL

> **NCT02246101** · — · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 406 (actual)

## Conditions studied

- Cardiac Disease
- Cardiopulmonary Disease
- Renal Disease
- Cardiovascular Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02246101
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-09-16
- **Final completion:** 2016-09-16
- **Target enrollment:** 406 (ACTUAL)
- **Last updated:** 2017-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02246101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02246101, "World Trade Center (WTC) RENAL". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02246101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*